{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT01157403",
      "OrgStudyIdInfo": {
        "OrgStudyId": "ldb201001"
      },
      "Organization": {
        "OrgFullName": "Third Military Medical University",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Autologous Transplantation of Mesenchymal Stem Cells for Treatment of Patients With Onset of Type 1 Diabetes",
      "OfficialTitle": "Autologous Transplantation of Mesenchymal Stem Cells for Treatment of Patients With Onset of Type 1 Diabetes"
    },
    "StatusModule": {
      "StatusVerifiedDate": "June 2013",
      "OverallStatus": "Unknown status",
      "LastKnownStatus": "Recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "July 2010"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "July 2014",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "August 2014",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "July 2, 2010",
      "StudyFirstSubmitQCDate": "July 6, 2010",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "July 7, 2010",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "June 15, 2013",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "June 18, 2013",
        "LastUpdatePostDateType": "Estimate"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor-Investigator",
        "ResponsiblePartyInvestigatorFullName": "Lu Debin",
        "ResponsiblePartyInvestigatorTitle": "Southwest Hospital",
        "ResponsiblePartyInvestigatorAffiliation": "Third Military Medical University"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Lu Debin",
        "LeadSponsorClass": "OTHER"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes"
    },
    "DescriptionModule": {
      "BriefSummary": "Type 1 diabetes mellitus (T1DM)is characterized by the autoimmune destruction of the pancreatic β cells; as a result, patients with T1DM are dependent on exogenous insulin to control their blood glucose continuously. Bone marrow-derived mesenchymal stem cells has been shown in many animal studies their potential cure for T1DM,which could not only address the need for β-cell replacement but also control of the autoimmune response to cells which express insulin. Therefore it is need to study the safety and efficacy of autologous bone marrow mesenchymal stem cells in treatment of newly diagnosed patients with T1DM.",
      "DetailedDescription": "Autologous transplantation of Bone marrow mesenchymal stem cells(approximately 2.5 x 106 cells/kg body weight) intravenously"
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Evidence of Liver Transplantation"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "mesenchymal stem cells"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 2",
          "Phase 3"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "N/A",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "Double",
          "DesignWhoMaskedList": {
            "DesignWhoMasked": [
              "Participant",
              "Investigator"
            ]
          }
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "80",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "mesenchymal stem cells",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "To study the safety and efficacy of autologous transplantation of bone marrow mesenchymal stem cells in treatment of newly diagnosed patients with T1DM.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Autologous transplantation"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Autologous transplantation",
            "InterventionDescription": "Autologous transplantation of bone marrow mesenchymal stem cells (approximately 2.5 x 106 cells/kg body weight) intravenously",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "mesenchymal stem cells"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "SWH2010A19"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "C peptide release test",
            "PrimaryOutcomeDescription": "The concentration of c-peptide at 90 minutes after the start of the C-peptide release test at 24 Months following the infusion or not with bone marrow mesenchymal stem cells",
            "PrimaryOutcomeTimeFrame": "6 Months after intervention"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nAbility to provide written informed consent from patients or Child guardian\nConfirmed diagnosis of type 1 diabetes by ADA criteria less than 18 weeks •\n\nExclusion Criteria:\n\nBody Mass Index >30\nPresence of acute stage as Active infection,recent myocardial infarction, recent cerebral vascular accident (CVA) or acute renal failure.\nSevere Organ damage(e.g. lung disease, or hematopoietic dysfunction, or liver dysfunction).\nInfectious diseases, e.g. HIV infection, or hepatitis B or C infection\nPresence of malignancy",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "10 Years",
      "MaximumAge": "40 Years",
      "StdAgeList": {
        "StdAge": [
          "Child",
          "Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "Chen bing, doctor",
            "CentralContactRole": "Contact",
            "CentralContactEMail": "903262619@qq.com"
          },
          {
            "CentralContactName": "lu debin, doctor",
            "CentralContactRole": "Contact",
            "CentralContactEMail": "ldb2005056@yahoo.com.cn"
          }
        ]
      },
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "chen bing, doctor",
            "OverallOfficialAffiliation": "Endocrine Department, the south west Hospital of the Third Military Medical University",
            "OverallOfficialRole": "Study Director"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Endocrine Department, the south west Hospital of the Third Military Medical University",
            "LocationStatus": "Recruiting",
            "LocationCity": "Chongqing",
            "LocationState": "Chongqing",
            "LocationZip": "400038",
            "LocationCountry": "China",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Chen Bing, doctor",
                  "LocationContactRole": "Contact",
                  "LocationContactEMail": "cb@mail.tmmu.com.cn"
                },
                {
                  "LocationContactName": "Lu Debin, doctor",
                  "LocationContactRole": "Contact",
                  "LocationContactEMail": "ldb2005056@yahoo.COM.CN"
                }
              ]
            }
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000003922",
            "ConditionMeshTerm": "Diabetes Mellitus, Type 1"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000003920",
            "ConditionAncestorTerm": "Diabetes Mellitus"
          },
          {
            "ConditionAncestorId": "D000044882",
            "ConditionAncestorTerm": "Glucose Metabolism Disorders"
          },
          {
            "ConditionAncestorId": "D000008659",
            "ConditionAncestorTerm": "Metabolic Diseases"
          },
          {
            "ConditionAncestorId": "D000004700",
            "ConditionAncestorTerm": "Endocrine System Diseases"
          },
          {
            "ConditionAncestorId": "D000001327",
            "ConditionAncestorTerm": "Autoimmune Diseases"
          },
          {
            "ConditionAncestorId": "D000007154",
            "ConditionAncestorTerm": "Immune System Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M6267",
            "ConditionBrowseLeafName": "Diabetes Mellitus",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M6269",
            "ConditionBrowseLeafName": "Diabetes Mellitus, Type 1",
            "ConditionBrowseLeafAsFound": "Type 1 Diabetes",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M10791",
            "ConditionBrowseLeafName": "Metabolic Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M24556",
            "ConditionBrowseLeafName": "Glucose Metabolism Disorders",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M7014",
            "ConditionBrowseLeafName": "Endocrine System Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M3781",
            "ConditionBrowseLeafName": "Autoimmune Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9352",
            "ConditionBrowseLeafName": "Immune System Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC18",
            "ConditionBrowseBranchName": "Nutritional and Metabolic Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC19",
            "ConditionBrowseBranchName": "Gland and Hormone Related Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC20",
            "ConditionBrowseBranchName": "Immune System Diseases"
          }
        ]
      }
    }
  }
}